End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,062 MXN | +8.97% | -.--% | +12.60% |
06-18 | T. Rowe Price Unveils New, Patent-Pending Framework | CI |
06-12 | Goldman Sachs Raises T. Rowe Price's PT to $113 From $110 | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's enterprise value to sales, at 3.24 times its current sales, is high.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.60% | 25.75B | - | ||
-3.02% | 117B | A- | ||
+3.26% | 94.38B | C+ | ||
+26.70% | 67.18B | C | ||
+7.06% | 64.45B | - | B+ | |
+15.06% | 44.79B | C+ | ||
+12.47% | 42.43B | A- | ||
+25.82% | 37.37B | A- | ||
-4.47% | 22.29B | A- | ||
-0.28% | 18.39B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TROW Stock
- TROW * Stock
- Ratings T. Rowe Price Group, Inc.